The Minds Behind the Mission

3

Caladrix is led by a global team with expertise in neurodegeneration, translational research, clinical drug development and company building. The executive team brings decades of experience in biotech, transporter biology and entrepreneurship across varied industries. The lead clinical investigators and board includes leaders in biomarker discovery, protein clearance mechanisms and FDA sanctioned neuroscience trial methodology.

Directors

Jonas Fischer

CO-FOUNDER & CEO

Dr. Markus Krohn

CO-FOUNDER & CSO

Max Brattig

CO-FOUNDER & CFO

Board

Prof. Peter Lansbury

CHAIRMAN

David Oxley

MEMBER OF THE BOARD

Michael Messemer

MEMBER OF THE BOARD

Edward Capel-Cure

MEMBER OF THE BOARD

Scientific Advisors

Prof. Henrik Zetterberg

Prof. Jens Wiltfang

Dr. Suzanne Hendrix

Prof. Michael Keusgen

Dr. Leon Hooftman

Dr. Marc Hentz

Dr. Manfred Windisch